These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16931226)

  • 1. Parathyromatosis and the challenge of treatment.
    Daphnis E; Stylianou K; Katsipi I; Stratigis S; Karamitopoulou E; Karkavitsas N; Kyriazis J
    Am J Kidney Dis; 2006 Sep; 48(3):502-5. PubMed ID: 16931226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyromatosis and recurrent hyperparathyroidism.
    Lentsch EJ; Withrow KP; Ackermann D; Bumpous JM
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):894-6. PubMed ID: 12925351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyromatosis: a cause for recurrent hyperparathyroidism.
    Lee PC; Mateo RB; Clarke MR; Brown ML; Carty SE
    Endocr Pract; 2001; 7(3):189-92. PubMed ID: 11421566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis.
    Jain M; Krasne DL; Singer FR; Giuliano AE
    Endocrine; 2017 Feb; 55(2):643-650. PubMed ID: 27743301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperparathyroidism caused by distant pulmonary lesions and parathyromatosis after ethanol injection/parathyroidectomy for secondary hyperparathyroidism.
    Nakamura M; Tanaka K; Fujii T
    Hemodial Int; 2017 Jul; 21(3):E45-E49. PubMed ID: 28078796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of cinacalcet HCl in a patient with end-stage renal failure and refractory secondary hyperparathyroidism due to parathyromatosis.
    Unbehaun R; Lauerwald W
    Clin Nephrol; 2007 Mar; 67(3):188-92. PubMed ID: 17390744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.
    Czosnowski LM; Hudson JQ; Canada RB
    Am J Med Sci; 2009 Apr; 337(4):300-1. PubMed ID: 19365180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective long-term management of parathyromatosis-related refractory hypercalcemia with a combination of denosumab and cinacalcet treatment.
    Tzotzas T; Goropoulos A; Karras S; Terzaki A; Siolos A; Doumas A; Zaramboukas T; Tigas S
    Hormones (Athens); 2022 Mar; 21(1):171-176. PubMed ID: 34993886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism.
    Hage MP; Salti I; El-Hajj Fuleihan G
    Metabolism; 2012 Jun; 61(6):762-75. PubMed ID: 22221828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis.
    Goldenberg MM
    Clin Ther; 1999 Mar; 21(3):432-41. PubMed ID: 10321413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parathyromatosis: An uncommon cause of recurrent hyperparathyroidism].
    Achour I; Charfi S; Chaabouni MA; Chakroun A; Guermazi F; Hammami B; Ghorbel A
    Rev Med Interne; 2017 Jan; 38(1):61-64. PubMed ID: 27083335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings.
    Tublin ME; Yim JH; Carty SE
    J Ultrasound Med; 2007 Jun; 26(6):847-51. PubMed ID: 17526617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hyperparathyroidism complicated by parathyromatosis.
    Stehman-Breen C; Muirhead N; Thorning D; Sherrard D
    Am J Kidney Dis; 1996 Oct; 28(4):502-7. PubMed ID: 8840938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent or persistent hyperparathyroidism.
    Wells SA; Debenedetti MK; Doherty GM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N158-62. PubMed ID: 12412795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence hyperparathyroidism caused by synchronous parathyroid carcinoma and parathyromatosis in a patient with long-term hemodialysis.
    Yang J; Lu X; Zhou P; Liu H; Wang J; Su X
    BMC Nephrol; 2023 Oct; 24(1):293. PubMed ID: 37794407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism.
    Kollmorgen CF; Aust MR; Ferreiro JA; McCarthy JT; van Heerden JA
    Surgery; 1994 Jul; 116(1):111-5. PubMed ID: 8023257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyromatosis: a very rare cause of recurrent primary hyperparathyroidism - case report and review of the literature.
    Haciyanli M; Karaisli S; Gucek Haciyanli S; Atasever A; Arikan Etit D; Gur EO; Acar T
    Ann R Coll Surg Engl; 2019 Nov; 101(8):e178-e183. PubMed ID: 31509000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent renal hyperparathyroidism caused by parathyromatosis.
    Matsuoka S; Tominaga Y; Sato T; Uno N; Goto N; Katayama A; Uchida K; Tsuzuki T
    World J Surg; 2007 Feb; 31(2):299-305. PubMed ID: 17219279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyromatosis following spontaneous rupture of a parathyroid adenoma: natural history and the challenge of management.
    Sim IW; Farrell S; Grodski S; Jung C; Ng KW
    Intern Med J; 2013 Jul; 43(7):819-22. PubMed ID: 23841761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.